ArriVent BioPharma Financial Ratios for Analysis 2021-2024 | AVBP

Fifteen years of historical annual and quarterly financial ratios and margins for ArriVent BioPharma (AVBP).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202320222021
13.7621.8423.63
---
---
---
---
---
---
---
---
---
---
---
---
45.2643.36106
-45.83-21.15-125.19
-42.51-20.19-119.91
-45.83-21.15-125.19
55.1267.1515.91
-26.08-34.17-17.70
-26.08-34.17-17.70

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-312021-12-31
25.5032.82-----
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-7.37-5.48-----
-7.37-5.48-----
-7.08-5.31-----
-7.37-5.48-----
8.859.49-----
-1.13-0.740.00-23.17-13.110.000.00
-1.13-0.74--23.17-13.11--